15
Jul
Jul
The FDA approved Nolvadex as hormonal therapy for treating breast cancer in 1998. It significantly decreases the risk of invasive cancer and cancer recurrence. Some people also take Nolvadex to minimize the likelihood of developing breast cancer. It is classified as anti-estrogen because, when you take this oral medication daily, it prevents cancer cells from […]